We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $63.9B
1-Year Est. Return 45.56%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+2.8%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.31%
AUM
$64.5B
AUM Growth
-$11.3B
Cap. Flow
-$10.1B
Cap. Flow %
-15.68%
Top 10 Hldgs %
12.13%
Holding
3,923
New
466
Increased
1,028
Reduced
1,682
Closed
737

Top Buys

Rank Stock Value
1
COST icon
Costco
COST
+$616M
2
NFLX icon
Netflix
NFLX
+$481M
3
MU icon
Micron Technology
MU
+$416M
4
TSLA icon
Tesla
TSLA
+$416M
5
PG icon
Procter & Gamble
PG
+$322M

Sector Composition

Rank Sector Weight
1 Technology 20.84%
2 Healthcare 15.77%
3 Consumer Discretionary 13.88%
4 Industrials 9.94%
5 Financials 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMP icon
2751
Compass Minerals
CMP
$1.12B
$310K ﹤0.01%
15,800
-100
-0.6% -$1.85K
AVGO icon
2752
Broadcom
AVGO
$2.02T
$308K ﹤0.01%
889
+62
+7% +$22.2K
VIVO
2753
VivoPower PLC
VIVO
$144M
$306K ﹤0.01%
+135,058
New +$464K
SNES icon
2754
SenesTech
SNES
$6.94M
$306K ﹤0.01%
142,800
+37,165
+35% +$116K
SKIN icon
2755
SkinHealth Systems
SKIN
$85.5M
$304K ﹤0.01%
218,891
+4,400
+2% +$6.36K
LVO icon
2756
LiveOne
LVO
$56.6M
$304K ﹤0.01%
64,408
+2,300
+4% +$10.9K
LXRX icon
2757
Lexicon Pharmaceuticals
LXRX
$1.05B
$303K ﹤0.01%
263,254
-29,146
-10% -$40K
TOTL icon
2758
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.01B
$302K ﹤0.01%
7,500
-63,530
-89% -$2.57M
SHLS icon
2759
Shoals Technologies Group
SHLS
$1.4B
$301K ﹤0.01%
35,400
-2,367,100
-99% -$21.3M
BOLT icon
2760
Bolt Biotherapeutics
BOLT
$6.57M
$301K ﹤0.01%
55,025
+26,400
+92% +$142K
LPCN icon
2761
Lipocine
LPCN
$17.2M
$300K ﹤0.01%
37,397
+1,300
+4% +$4.37K
CARL
2762
Carlsmed
CARL
$381M
$300K ﹤0.01%
+24,300
New +$323K
SLNH icon
2763
Soluna Holdings
SLNH
$208M
$299K ﹤0.01%
+255,942
New +$583K
MKTW icon
2764
MarketWise
MKTW
$53.6M
$299K ﹤0.01%
19,899
+900
+5% +$14.1K
SLDB icon
2765
Solid Biosciences
SLDB
$974M
$298K ﹤0.01%
52,800
-410,900
-89% -$2.23M
BCE icon
2766
BCE
BCE
$21.6B
$298K ﹤0.01%
+12,500
New +$291K
FBIO icon
2767
Fortress Biotech
FBIO
$94M
$297K ﹤0.01%
81,100
+40,300
+99% +$115K
IMXI icon
2768
International Money Express
IMXI
$347M
$296K ﹤0.01%
+19,300
New +$290K
RNAC icon
2769
Cartesian Therapeutics
RNAC
$266M
$296K ﹤0.01%
+41,100
New +$332K
FCAP icon
2770
First Capital
FCAP
$218M
$296K ﹤0.01%
5,000
-500
-9% -$24.7K
GDOT icon
2771
Green Dot
GDOT
$768M
$295K ﹤0.01%
+23,000
New +$286K
TLPH icon
2772
Talphera
TLPH
$63.3M
$293K ﹤0.01%
257,380
+207,166
+413% +$250K
VNO icon
2773
Vornado Realty Trust
VNO
$7.45B
$293K ﹤0.01%
8,799
-172,000
-95% -$6.28M
ARTW icon
2774
Arts-Way Manufacturing Co
ARTW
$13.9M
$293K ﹤0.01%
124,474
+60,400
+94% +$148K
CINT icon
2775
CI&T Inc
CINT
$468M
$292K ﹤0.01%
71,700
-143,800
-67% -$654K

Similar funds

Jim Simons's Q4 2025 Portfolio in Review

As of Q4 2025, Jim Simons held 3,923 positions worth $64.5B, down 15% from $75.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jim Simons withdrew a net $10.1B in Q4 2025, closing 737 positions and reducing 1,682 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $354M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Jim Simons opened a new position in ServiceNow worth $204M.

  • Jim Simons's largest Q4 2025 buy was ServiceNow: 1,331,977 shares worth $204M.
  • Jim Simons added most to Costco in Q4 2025, an estimated $616M increase.
  • Jim Simons's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $885M.
  • Jim Simons fully exited Meta Platforms (Facebook) in Q4 2025, selling an estimated $354M.
  • Jim Simons's ten largest holdings make up 12% of its $64.5B portfolio in Q4 2025.
  • Jim Simons opened 466 new positions and closed 737 in Q4 2025.
  • Jim Simons's portfolio value fell 15% quarter-over-quarter to $64.5B.

Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.